Track Record

Since 2019, Domainex has worked with 115 biotech companies, 30 academic/patient foundations and 80% of the top 10 big pharma from the UK, Europe, The US, Japan, Korea and Australia.

worldwide-graphic-small-small

Success Spanning a Wide Range of Therapeutic Areas

success-graphic-large
patients-icon-small
paper-icon-small
qualified-icon-small
extensions-icon-small

The publications and case studies our clients have allowed us to put in the public domain also illustrate our proven record of success. 

In addition, we have received several awards recognising our customer focus and innovative approach to drug discovery.